TABLE OF CONTENTS
1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW OF MENA & GCC ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET 20
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 22
2 MARKET SEGMENTATION 24
2.1 MARKETS COVERED 24
2.2 GEOGRAPHICAL SCOPE 25
2.3 YEARS CONSIDERED FOR THE STUDY 25
2.4 CURRENCY AND PRICING 25
2.5 DBMR TRIPOD DATA VALIDATION MODEL 26
2.6 MULTIVARIATE MODELLING 29
2.7 PRODUCTS LIFELINE CURVE 29
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 30
2.9 DBMR MARKET POSITION GRID 31
2.10 MARKET END USER COVERAGE GRID 32
2.11 VENDOR SHARE ANALYSIS 34
2.12 SECONDARY SOURCES 35
2.13 ASSUMPTIONS 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHTS 39
4.1 PESTEL ANALYSIS 40
4.2 PORTERS FIVE FORCES 41
4.3 MENA & GCC ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, PRICING 42
5 MENA & GCC ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: REGULATIONS 43
6 MARKET OVERVIEW 45
6.1 DRIVERS 47
6.1.1 RISING GERIATRIC POPULATION 47
6.1.2 INCREASING RISK OF OSTEOPOROSIS AND OSTEOARTHRITIS 47
6.1.3 TECHNOLOGICAL ADVANCEMENT IN ORTHOPEDIC IMPLANTS 47
6.1.4 RISING AWARENESS ABOUT ORTHOPEDIC IMPLANT 48
6.2 RESTRAINTS 49
6.2.1 HIGH COST ASSOCIATED WITH PROCEDURES INVOLVING ORTHOPEDIC IMPLANTS TREATMENT 49
6.2.2 PRODUCT RECALL 49
6.3 OPPORTUNITIES 50
6.3.1 RISING HEALTHCARE INFRASTRUCTURE 50
6.3.2 INCREASE IN DEMAND FOR MINIMALLY INVASIVE PROCEDURES 50
6.3.3 INCREASING NUMBER OF JOINT REPLACEMENTS AND SPORTS ACCIDENT 51
6.3.4 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 51
6.4 CHALLENGES 52
6.4.1 INADEQUATE REIMBURSEMENT COVERAGE 52
6.4.2 STRINGENT GOVERNMENT POLICIES FOR APPROVAL OF ORTHOPEDIC IMPLANTS 52
6.4.3 SIDE-EFFECTS OF ORTHOPEDIC IMPLANTS 53
7 MENA & GCC ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCTS 54
7.1 OVERVIEW 55
7.2 RECONSTRUCTIVE JOINT REPLACEMENTS 58
7.2.1 LOWER EXTREMITY RECONSTRUCTION 58
7.2.1.1 KNEE REPLACEMENT IMPLANTS 59
7.2.1.2 HIP REPLACEMENT IMPLANTS 59
7.2.1.3 FOOT IMPLANTS 59
7.2.1.4 ANKLE IMPLANTS 59
7.2.2 UPPER EXTREMITY RECONSTRUCTION 59
7.2.2.1 SHOULDER IMPLANTS 59
7.2.2.2 ELBOW IMPLANTS 59
7.2.2.3 HAND WRIST IMPLANTS 60
7.3 SPINAL IMPLANTS 60
7.3.1 SPINAL FUSION DEVICES 61
7.3.1.1 THORACOLUMBAR DEVICES 61
7.3.1.2 CERVICAL FIXATION DEVICES 61
7.3.1.3 INTERBODY FUSION DEVICES 61
7.3.2 NON-FUSION DEVICES/MOTION PRESERVATION DEVICES 61
7.3.2.1 BALLOON KYPHOPLASTY DEVICES 62
7.3.2.2 VERTEBROPLASTY DEVICES 62
7.3.3 INVASIVE SPINAL BONE STIMULATORS 62

7.4 TRAUMA & CRANIOMAXILLOFACIAL 62
7.4.1 SCREWS 63
7.4.2 PLATES 63
7.4.3 STAPLES 63
7.4.4 OTHERS 63
7.5 DENTAL IMPLANTS 63
7.5.1 ROOT FORM DENTAL IMPLANTS 64
7.5.2 PLATE FORM DENTAL IMPLANTS 64
7.6 ORTHOBIOLOGICS 64
7.6.1 ALLOGRAFTS 65
7.6.1.1 MACHINED ALLOGRAFTS 65
7.6.1.2 DEMINERALISED BONE MATRIX 65
7.6.2 BONE GRAFT SUBSTITUTES 65
7.6.2.1 BONE MORPHOGENIC PROTEINS (BMP) 65
7.6.2.2 SYNTHETIC BONE GRAFTS 66
7.6.3 CELL BASED MATRICES 66
8 MENA & GCC ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY DEVICE TYPES 67
8.1 OVERVIEW 68
8.2 INTERNAL FIXATION DEVICES 71
8.3 EXTERNAL FIXATION DEVICES 71
8.3.1 ORTHOPEDIC PLATES 72
8.3.2 ORTHOPEDIC SCREWS 72
8.3.3 ORTHOPEDIC NAILS 72
8.3.4 ORTHOPEDIC RODS/WIRES 72
8.3.5 FIXATION PINS 72
8.3.6 OTHERS 72
9 MENA & GCC ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY BIOMATERIAL 73
9.1 OVERVIEW 74
9.2 POLYMERIC BIOMATERIALS 77
9.2.1 TITANIUM 77
9.2.2 COBALT 77
9.2.3 CHROMIUM 77
9.2.4 MOLYBDENUM 78
9.3 METALLIC BIOMATERIALS 78
9.4 CERAMIC BIOMATERIALS 78
9.5 NATURAL BIOMATERIALS 78
9.6 OTHERS 79
10 MENA & GCC ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES 80
10.1 OVERVIEW 81
10.2 OPEN SURGERY 84
10.2.1 INTERNAL FIXATION DEVICES 84
10.2.2 EXTERNAL FIXATION DEVICES 84
10.3 MINIMALLY INVASIVE SURGERY (MIS) 84
10.3.1 INTERNAL FIXATION DEVICES 85
10.3.2 EXTERNAL FIXATION DEVICES 85
11 MENA & GCC ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER 86
11.1 OVERVIEW 87
11.2 HOSPITALS 90
11.3 AMBULATORY CARE CENTER 90
11.4 SPECIALIZED CLINICS 90
11.5 ORTHOPEDIC CENTERS 91
11.6 OTHERS 91
12 MENA & GCC ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY OWNERSHIP TYPE 92
12.1 OVERVIEW 93
12.2 GOVERNMENT 96
12.3 PRIVATE 97
13 MENA & GCC ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY COUNTRY 98
13.1 MENA & GCC 98
13.1.1 SAUDI ARABIA 103
13.1.2 UAE 109
13.1.3 EGYPT 116
13.1.4 ISRAEL 122
13.1.5 KUWAIT 128
13.1.6 REST OF MENA & GCC 134

14 MENA & GCC ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: COMPANY LANDSCAPE 135
14.1 COMPANY SHARE ANALYSIS: MENA &GCC 135
15 SWOT ANALYSIS 136
16 COMPANY PROFILE 137
16.1 DEPUY SYNTHES (A SUBSIDIARY OF JNJ) INC. 137
16.1.1 COMPANY SNAPSHOT 137
16.1.2 REVENUE ANALYSIS 137
16.1.3 PRODUCT PORTFOLIO 138
16.1.4 RECENT DEVELOPMENTS 139
16.2 ZIMMER BIOMET 141
16.2.1 COMPANY SNAPSHOT 141
16.2.2 REVENUE ANALYSIS 141
16.2.3 PRODUCT PORTFOLIO 142
16.2.4 RECENT DEVELOPMENTS 143
16.3 SMITH & NEPHEW PLC 144
16.3.1 COMPANY SNAPSHOT 144
16.3.2 REVENUE ANALYSIS 144
16.3.3 PRODUCT PORTFOLIO 145
16.3.4 RECENT DEVELOPMENTS 145
16.4 MEDTRONIC 147
16.4.1 COMPANY SNAPSHOT 147
16.4.2 REVENUE ANALYSIS 147
16.4.3 PRODUCT PORTFOLIO 148
16.4.4 RECENT DEVELOPMENTS 148
16.5 STRYKER 149
16.5.1 COMPANY SNAPSHOT 149
16.5.2 REVENUE ANALYSIS 149
16.5.3 PRODUCT PORTFOLIO 150
16.5.4 RECENT DEVELOPMENTS 151
16.6 GENERAL ELECTRIC 152
16.6.1 COMPANY SNAPSHOT 152
16.6.2 REVENUE ANALYSIS 152
16.6.3 PRODUCT PORTFOLIO 153
16.6.4 RECENT DEVELOPMENTS 153

16.7 ABOUHAMELA GROUP 154
16.7.1 COMPANY SNAPSHOT 154
16.7.2 PRODUCT PORTFOLIO 154
16.7.3 RECENT DEVELOPMENT 154
16.8 ARTHREX, INC. 155
16.8.1 COMPANY SNAPSHOT 155
16.8.2 PRODUCT PORTFOLIO 155
16.8.3 RECENT DEVELOPMENTS 156
16.9 B. BRAUN MELSENGEN AG 157
16.9.1 COMPANY SNAPSHOT 157
16.9.2 REVENUE ANALYSIS 157
16.9.3 PRODUCT PORTFOLIO 158
16.9.4 RECENT DEVELOPMENTS 159
16.10 BONETECH MEDISYS P.V.T.L.T.D 160
16.10.1 COMPANY SNAPSHOT 160
16.10.2 PRODUCT PORTFOLIO 160
16.10.3 RECENT DEVELOPMENT 160
16.11 CANWELL MEDICAL CO, LTD. 161
16.11.1 COMPANY SNAPSHOT 161
16.11.2 PRODUCT PORTFOLIO 161
16.11.3 RECENT DEVELOPMENTS 162
16.12 CHANGZHOU WASTON MEDICAL APPLIANCES CO., LTD. 163
16.12.1 COMPANY SNAPSHOT 163
16.12.2 PRODUCT PORTFOLIO 163
16.12.3 RECENT DEVELOPMENT 164
16.13 CONMED CORPORATION 165
16.13.1 COMPANY SNAPSHOT 165
16.13.2 REVENUE ANALYSIS 165
16.13.3 PRODUCT PORTFOLIO 166
16.13.4 RECENT DEVELOPMENTS 167
16.14 CORIN GROUP 168
16.14.1 COMPANY SNAPSHOT 168
16.14.2 PRODUCT PORTFOLIO 168
16.14.3 RECENT DEVELOPMENTS 169
16.15 CUREX 170
16.15.1 COMPANY SNAPSHOT 170
16.15.2 PRODUCT PORTFOLIO 170
16.15.3 RECENT DEVELOPMENT 170

16.16 DJO, LLC (A SUBSIDIARY OF COLFAX CORPORATION) 171
16.16.1 COMPANY SNAPSHOT 171
16.16.2 REVENUE ANALYSIS 171
16.16.3 PRODUCT PORTFOLIO 172
16.16.4 RECENT DEVELOPMENTS 172
16.17 X LTD. 174
16.17.1 COMPANY SNAPSHOT 174
16.17.2 PRODUCT PORTFOLIO 174
16.17.3 RECENT DEVELOPMENT 174
16.18 EGIFIX MEDICAL 175
16.18.1 COMPANY SNAPSHOT 175
16.18.2 PRODUCT PORTFOLIO 175
16.18.3 RECENT DEVELOPMENT 175
16.19 GLOBUS MEDICAL 176
16.19.1 COMPANY SNAPSHOT 176
16.19.2 REVENUE ANALYSIS 176
16.19.3 PRODUCT PORTFOLIO 177
16.19.4 RECENT DEVELOPMENTS 177
16.20 INTEGRA LIFESCIENCES 179
16.20.1 COMPANY SNAPSHOT 179
16.20.2 REVENUE ANALYSIS 179
16.20.3 PRODUCT PORTFOLIO 180
16.20.4 RECENT DEVELOPMENTS 180
16.21 3M 182
16.21.1 COMPANY SNAPSHOT 182
16.21.2 REVENUE ANALYSIS 182
16.21.3 PRODUCT PORTFOLIO 183
16.21.4 RECENT DEVELOPMENT 183
16.22 NARANG MEDICAL LIMITED 184
16.22.1 COMPANY SNAPSHOT 184
16.22.2 PRODUCT PORTFOLIO 184
16.22.3 RECENT DEVELOPMENT 184
16.23 ORTHOMED 185
16.23.1 COMPANY SNAPSHOT 185
16.23.2 PRODUCT PORTFOLIO 185
16.23.3 RECENT DEVELOPMENT 186
16.24 SAMAY SURGICAL 187
16.24.1 COMPANY SNAPSHOT 187
16.24.2 PRODUCT PORTFOLIO 187
16.24.3 RECENT DEVELOPMENT 188
16.25 W. L. GORE & ASSOCIATES, INC. 189
16.25.1 COMPANY SNAPSHOT 189
16.25.2 PRODUCT PORTFOLIO 189
16.25.3 RECENT DEVELOPMENTS 189
17 QUESTIONNAIRE 190
18 RELATED REPORTS 193

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.